Koers Jounce Therapeutics, Inc.
Aandelen
JNCE
US4811161011
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 18 M€ | +3,26% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,58% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-10,28% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |